Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
In-licensing

products in dermatology, diabetology , respiratory and muscle-skeletal

Abiogen Pharma
products in dermatology, diabetology , respiratory and muscle-skeletal

Full description

Abiogen Pharma spa an Italian Pharmaceutical company very active in the Italian market is looking for new products to be inserted in its core therapeutical areas : dermatology, diabetology, respiratory and muscle-skeletal.

We look for CTD dossier ready to be filed.

Development status

Registered

Type of business relationship sought

Interested in licensing in.

Licensing contact

Ms Giovanna Naldini
Licensing and Business Development
Request more information

More information

For more information about the product please visit website.

Company details

Abiogen Pharma
Pharmaceutical research, product lines, toll manufacturing

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Research Partnership for Due Diligence Execution
Yissum Technology Transfer Hebrew University
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2009 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us